STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNY
  4. [6-K] Sanofi American Current Report (Foreign Issuer)

[6-K] Sanofi American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SNY logo
Sanofi FR

NASDAQ:SNY

SNY Rankings

#111 Ranked by Market Cap
#715 Ranked by Dividends

SNY Latest News

Jun 26, 2025
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts
Jun 2, 2025
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
May 22, 2025
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
May 20, 2025
Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)
May 14, 2025
Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing

SNY Latest SEC Filings

Jul 2, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)
Jun 24, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)

SNY Stock Data

120.10B
2.53B
0%
10.61%
0.22%
Drug Manufacturers - General
Healthcare
Link
France
Paris